EDI Health Group, Inc. – Trademark Portfolio
Entity Type: 03
EDI Health Group, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PAYCONNECT, CLAIMCONNECT, and DENTALXCHANGE. The owner is based in Irvine, CA.
17701 Cowan, Ste. 250
Irvine, CA 92614
Showing of trademarks Trademarks
Trademark Classifications
EDI Health Group, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does EDI Health Group, Inc. have?
EDI Health Group, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned, 3 cancelled.
What trademark classes does EDI Health Group, Inc. file in?
EDI Health Group, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are EDI Health Group, Inc.'s most well-known trademarks?
EDI Health Group, Inc.'s registered trademark portfolio includes well-known marks such as PAYCONNECT, CLAIMCONNECT, and DENTALXCHANGE. These are among 3 currently registered trademarks in the portfolio.
What is EDI Health Group, Inc.'s trademark registration success rate?
EDI Health Group, Inc. has a 38% trademark registration rate, with 3 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.